Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CPI Card Group
PMTS
$224M
| $285K | ﹤0.01% |
19,623
+2,929
| +18% | +$39.6K |
|
3252
Brown-Forman Class A
BF.A
$12.3B
| $283K | ﹤0.01% |
10,552
-16,932
| -62% | -$461K |
|
3253
Hanover Bancorp
HNVR
$179M
| $281K | ﹤0.01% |
13,006
| – | – |
|
3254
Seres Therapeutics
MCRB
$48.1M
| $281K | ﹤0.01% |
31,630
+261
| +0.8% | +$3.06K |
|
3255
Maui Land & Pineapple Co
MLP
$341M
| $280K | ﹤0.01% |
18,193
-3,635
| -17% | -$60.2K |
|
3256
Eastern Company
EML
$146M
| $278K | ﹤0.01% |
13,759
-2,285
| -14% | -$43.3K |
|
3257
Nkarta
NKTX
$162M
| $276K | ﹤0.01% |
130,975
+1,800
| +1% | +$4.03K |
|
3258
X4 Pharmaceuticals
XFOR
$363M
| $276K | ﹤0.01% |
66,749
-39
| -0.1% | -$146 |
|
3259
The Joint Corp
JYNT
$119M
| $274K | ﹤0.01% |
31,002
-35,619
| -53% | -$324K |
|
3260
Union Bankshares
UNB
$114M
| $273K | ﹤0.01% |
11,210
| – | – |
|
|
ANDG
3261
Andersen Group
ANDG
$4.84B
| $272K | ﹤0.01% |
+10,004
| New | +$234K |
|
|
AVBH
3262
Avidbank Holdings
AVBH
$349M
| $272K | ﹤0.01% |
9,546
-1,154
| -11% | -$32.6K |
|
|
NREF
3263
NexPoint Real Estate Finance
NREF
$316M
| $272K | ﹤0.01% |
20,171
-3,746
| -16% | -$53.6K |
|
3264
Riverview Bancorp
RVSB
$107M
| $268K | ﹤0.01% |
48,776
-8,459
| -15% | -$44.6K |
|
3265
Cardiff Oncology
CRDF
$64.3M
| $267K | ﹤0.01% |
164,708
-23,947
| -13% | -$49.2K |
|
3266
Sutro Biopharma
STRO
$379M
| $263K | ﹤0.01% |
+10,577
| New | +$191K |
|
3267
Lifeway Foods
LWAY
$465M
| $263K | ﹤0.01% |
13,615
-1,791
| -12% | -$38.1K |
|
3268
ReposiTrak
TRAK
$148M
| $263K | ﹤0.01% |
34,609
+238
| +0.7% | +$2.29K |
|
3269
Shattuck Labs
STTK
$710M
| $263K | ﹤0.01% |
40,881
+20,000
| +96% | +$94.9K |
|
3270
Global Water Resources
GWRS
$212M
| $262K | ﹤0.01% |
34,572
-410
| -1% | -$3.45K |
|
3271
RCM Technologies
RCMT
$196M
| $262K | ﹤0.01% |
13,709
-1,714
| -11% | -$33.3K |
|
3272
Bakkt Inc
BKKT
$333M
| $261K | ﹤0.01% |
35,526
-4,708
| -12% | -$55.8K |
|
|
RPT
3273
Rithm Property Trust
RPT
$90.5M
| $261K | ﹤0.01% |
19,503
-1,202
| -6% | -$18.1K |
|
|
URG
3274
Ur-Energy
URG
$485M
| $261K | ﹤0.01% |
175,179
+150
| +0.1% | +$245 |
|
3275
Finance of America Companies
FOA
$204M
| $258K | ﹤0.01% |
15,533
-2,708
| -15% | -$56K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.